Decrease in pregnancy rate after endometrial scratch in women undergoing a first or second in vitro fertilization. A multicenter randomized controlled trial 
Introduction
Success of assisted reproductive technologies (ART) remains relatively low with the European registers reporting a pregnancy rate per embryo transfer of around 30% (European IVF-monitoring Consortium (EIM) et al., 2017) .
The embryo implantation of in vitro fertilization (IVF) is the limiting step, and its failure can be related to inappropriate ovarian stimulation, embryo abnormalities, sub-optimal embryonic culture conditions, embryo transfer process and/or a non-receptive endometrium (Karimzadeh et al., 2009) . Several studies have focused on endometrial receptivity at the time of embryo transfer. Among the numerous medical approaches that have been proposed to improve implantation (Khairy et al., 2007; Revelli et al., 2008; Segev et al., 2010) , endometrial scratch (ES) in the cycle preceding IVF may be one of the most effective in improving endometrial receptivity (El-Toukhy et al., 2012; Potdar et al., 2012; Nastri et al., 2014 Nastri et al., , 2015b . Barash et al. were the first to report an increase in pregnancy rate in patients undergoing ES before IVF. Later, Raziel et al. and Zhou et al. confirmed these results (Barash et al., 2003; Raziel et al., 2007; Zhou et al., 2008) . The mechanism underlying this process remains unclear but several hypotheses have been suggested (Zhou et al., 2008; Gnainsky et al., 2010; Dekel et al., 2014; Siristatidis et al., 2014) . Firstly, a local scratch in the endometrium might induce the endometrium decidualization and thus increase its receptivity to the embryo (Gnainsky et al., 2010) . Secondly, it might provoke the wound healing, involving a mass secretion of different cytokines and growth factor, which are beneficial for embryo implantation (Cakmak and Taylor, 2011) . Lastly, it might promote the maturation of the endometrium (Nastri et al., 2015b) .
A recent systematic review reported that, even though endometrial scratch is associated with improved reproductive outcomes, more evidence is needed concerning the benefit in women undergoing their first or second IVF cycle (Nastri et al., 2015b) .
The aim of this study was to assess the impact of ES in the cycle preceding IVF on clinical pregnancy rate (CPR) in women undergoing their first or second IVF attempt.
Materials and Methods

Patients
We included patients from three French reproductive centers (Gynecology and obstetrics center in Pessac, Bordeaux University Hospital and Toulouse University Hospital). The study included women aged 18-38 years old, presenting with primary or secondary infertility, undergoing a first or second IVF attempt, with regular menstrual cycles (between 27 and 32 days) and FSH levels ≤2IU/L. Patients were excluded from the study if they were enrolled or had participated to in oocyte donation program, presented a BMI > 35, had hydrosalpinx, uterine deformations, uterine fibroids (≥4 and the largest > 5 cm), abnormal gynecological bleeding of unknown origin, or ongoing vaginal infection, had been pre-treated with estrogen-progesterone or estradiol pills, or were participating in another medically assisted reproduction study.
The study was approved by local ethics committees and was carried out in accordance with the principles of Good Clinical Practice and the Declaration of Helsinki. Patients were required to sign a written informed consent form to participate in the study (Clinical trial registration number: NCT01064193). The study is reported according to CONSORT guidelines.
Study design
A randomized controlled multi-center, two-arm, parallel trial was conducted. The randomization sequence was generated using SAS Software (PLAN procedure, Copyright (c) 2002 by SAS Institute Inc., Cary, NC, USA) and was stratified by center with a 1:1 allocation using random block sizes of 4 and 6. Patients included in the study were randomly assigned by the investigator to one of the following arms: (i) the ES arm: fresh IVF-or ICSI-embryo transfer after controlled ovarian hyperstimulation plus local scratch to the endometrium on the cycle preceding IVF; (ii) non-ES arm: fresh IVF-or ICSI-embryo transfer treated after controlled ovarian stimulation alone. Randomization was stratified by site and was performed using a centralized web-based service.
Local ES was performed between Day 20 and Day 24 of the cycle preceding ovarian stimulation using a device for endometrial biopsy (Pipelle de Cornier, CCD international, PROMIDED, Neuilly-en Thelle, France). A sample of uterine mucosa (representative of the whole uterus cavity) was retrieved by suction and rotation. The sample was placed in a flask containing formaldehyde. A piece of the biopsy was sent for anatomical and -pathological examination. Patients started their IVF treatment in the subsequent cycle. Ovarian stimulation used a combination of recombinant FSH and gonadotrophin-releasing hormone (GnRH) agonist or GnRH antagonist without prior estrogen administration. Oocyte retrieval, IVF (with or without ICSI) and embryo transfer procedures were carried out according to standard protocols, 2 or 3 days after fertilization (Terriou et al., 2006) . Embryo morphology was classified according to the Giorgetti 4-point score. In this classification embryos are assigned 1 point each if, on Day 2, they (i) are cleaved, (ii) present no fragmentation, (iii) display no irregularities and (iv) have four cells (Giorgetti et al., 1995) .
Endpoints
The primary endpoint was clinical pregnancy rate (CPR), defined by the presence of at least one intrauterine gestational sac with fetal heartbeat. Secondary endpoints were: rate of clinically ongoing pregnancy in the first trimester (defined as pregnancies ≥ 12 weeks), rate of embryo implantation, rate of miscarriage in the first trimester, rate of extrauterine pregnancy, rate of multiple pregnancy and tolerance of the intervention. Adverse events (infections, pain, bleeding) occurring during and after scratching were collected after the intervention and at the end of the study. Pain was assessed with a visual analog scale (VAS). Type of pain was determined by means of a questionnaire administered by a nurse or physician by telephone or in consultation.
Statistical methods
The sample size was determined using the nQuery Advisor ® 7.0 software (Statistical Solutions, Saugus, MA, USA) based on the Chi squared test. Assuming a CPR of 25% in the non-ES arm and a 40% increase in the CPR in the ES arm, the required sample size to obtain 80% power at an alpha risk of 5% was estimated at 152 patients for each study arm. In order to take into consideration a 15% of patients without oocyte, embryo transfer and/or patients stopping treatment, 179 patients had to be enrolled in each arm, that is, 358 patients. The analysis of the primary outcome was conducted on an intention-totreat (ITT) basis (analysis based on the initial treatment assignment and not on the treatment eventually received) and was carried out in the population comprising all-treated patients (patients having received an embryo transfer). This analysis was also conducted on an as-treated principle (considering the treatment effectively received). It was assumed that missing values represented a failure (no clinical pregnancy). A subgroup analysis was performed comparing women undergoing the first attempt versus those undergoing a second attempt. Secondary analyses were based on the same principles, but on available data. All comparisons between the two groups were done using a logistic regression model adjusted for age, BMI, infertility etiology, quality of embryo and smoking status. These factors were considered, a priori, as being strong predictors of clinical pregnancy. Statistical analyses were carried out using SAS software (Version 9.3).
An unplanned interim analysis of the primary endpoint was carried out through both a futility analysis and a formal between-group comparison with adjustment of the alpha risk. The futility analysis was performed using a Bayesian method to calculate the predicted power at the end of inclusions considering the observations at the time of the interim analysis (Dmitrienko and Wang, 2006) . The adjustment of the alpha risk used the method proposed by O'Brien and Fleming (O'Brien and Fleming, 1979) . Consequently, the final differences between the two arms were considered statistically significant at a P value of less than 0.0446 for the primary outcome only.
Results
Patients
Inclusions for this study started in February 2010 and stopped prematurely in July 2014 on the recommendation of an independent data monitoring committee after an unplanned interim analysis. This analysis was prompted by the tendency towards lower pregnancy rates observed in the ES arm. The futility analysis, using several hypotheses, yielded a maximal predicted power of 22% to demonstrate a difference between ES and no ES.
At the time of study closure, 191 of the planned 358 patients had been included in the study. Fig. 1 shows the CONSORT flow diagram. Ninety-eight (51.3%) patients were assigned to the ES arm and 93 (48.7%) to the non-ES arm. One patient in the ES arm was wrongfully included (presented a contra-indication) and was finally excluded from the analyses. Patient baseline characteristics of ES and non-ES patients are presented in Table I for the included and for the treated population. Age, BMI and infertility status were well balanced between the two arms. For 63 (67.7%) patients in the non-ES arm this was the first IVF attempt versus 75 (77.3%) in the ES arm. The rate of smokers in the ES arm was greater than in the non-ES arm in both populations.
Characteristics of ART
ES was performed at cycle Day 20.6 (mean, standard deviation (SD) = 2.2 days) of the cycle preceding the IVF attempt. Of the 97 patients in the intervention arm, only 80 (81.6%) presented to the scratch procedure. Sixteen patients did not attend the visit and the remaining patient encountered a randomization error. Eight (10%) of the 80 patients who attended the visit could not undergo the intervention: local scratch could not be carried out for four patients, three patients presented with a cervical stenosis and one patient presented no uterine passage.
As shown in Table II , there was no clinically significant difference in the ART characteristics between the two arms. In total, 132 transfer cycles were performed, 68 in the ES arm and 64 in the non-ES arm. The number of Grade 1 embryos transferred was greater in the non-ES arm (23/64, 35.9%) than in the ES arm (19/68, 27.9%).
Pregnancies
Five weeks after embryo transfer, the CPR was 35.9% (23/64) in the non-ES arm versus 23.5% (16/68) in the ES arm (hazard ratio (HR) = 0.43; 95% CI, 0.18-1.02; P = 0.0568) (Fig. 2 and Table III) . For women undergoing their first IVF attempt, CPR was 34.1% (15/44) in the non-ES arm and 21.2% (11/52) in the ES arm (odds ratio (OR) = 0.46; 95% CI, 0.17-1.29; P = 0.1403). For women undergoing their second CPR was 40.0% (8/20) in the non-ES arm and 31.3% (5/16) in the ES arm (OR = 0.45; 95% CI, 0.07-2.7; P = 0.3798). The as-treated analysis (considering the treatment effectively received) yielded clinical pregnancy rates of 30.8% (24/78) in the non-ES arm, and 27.8% (15/ 54) in the ES arm (HR = 0.84; 95% CI, 0.37-1.91; P = 0.6747). The rate of ongoing pregnancy was 20.6% (14/68) in the ES and 31.7% (20/63, 1 missing data) in the non-ES arm (OR = 0.45; 95% CI, 0.18-1.2 P = 0.0866) ( Table III) .
Of 50 patients in the ES arm having received the embryo transfer, 40 (80.0%) patients reported having felt pain during the procedure. Pain resolved quickly for 31 women and the questionnaire was incomplete for the remaining 3. Among the six patients for whom pain did not resolve quickly, three felt a contraction-like pain, one patient felt period-like pain, one patient felt piercing pain and one patient stabbing pain. Three patients also reported bleeding after the ES. All patients Abbreviations: ES = endometrial sratch; BMI = body mass index; FSH = follicle-stimulating hormone; AMH = anti-müllerian hormone; SD = standard deviation; IVF = in vitro fecundation. No clinically significant difference was found between the two randomized groups for any parameter.
reported no regrets for having undergone the scratch. Details on pain scores and types are presented in Table IV . Twenty-three (17.4%) of the 132 patients having undergone the embryo transfer reported adverse events (AEs), 8/23 patients in the ES arm versus 15/23 patients in the non-ES arm. Most common AEs in the non-ES arm were ovarian hyperstimulation (4/15, 26.7%), pelvic pain (2/15, 13.3%) and abdominal pain (2/15, 13.3%). Most commonly reported AEs in the ES arm were metrorrhagia (2/8, 25%) and pelvic pain (2/8, 25%). One of the metrorrhagia cases was related to the study intervention. two patients reported ovarian hyperstimulation and one an allergy to a specific drug. None of the AEs were related to the study procedures as assessed by the investigator.
Discussion
This study indicates that ES is of no benefit in patients undergoing their first or second IVF/ICSI cycle: furthermore, the data suggest that ES has a detrimental effect on pregnancy outcome. There is increasing evidence in the literature about the beneficial effect of ES in women after several failed IVF attempts (Raziel et al., 2007; Karimzadeh et al., 2009; Narvekar et al., 2010; Öztürk İnal et al., 2012; Nastri et al., 2014) . A Cochrane systematic review published in 2015 concluded that ES significantly improved clinical pregnancy rate (CPR) (RR = 1.34; 95% CI, 1.21-1.61; P = 0.002) and live birth (LBR) or ongoing pregnancy rate (RR = 1.42; 95% CI, 1.08-1.85; P = 0.01) (Nastri et al., 2015b) . This review included 14 RCT's with 2128 women; seven studies included women with previous IVF failures, five included women regardless of the number of previous IVF cycles and one included only women undergoing their first IVF cycle. In a recent retrospective study, Reljic et al. reported that local ES is an independent prognostic factor for pregnancy (OR = 1.73; 95% CI 1.02-2.92): they included women with at least three previous failed ICSI/IVF cycles (Reljič et al., 2017 ).
These studies demonstrate that endometrial scratch may improve reproductive outcomes in women undergoing ART by inducing changes in the endometrium. Conversely, Yeung et al. carried out an RCT with 300 infertile women and reported no significant difference in the ongoing pregnancy (P = 0.375) or implantation (P = 0.120) rates between patients in the ES group and the non-ES group (Yeung et al., 2014) . Most patients (>70%) were undergoing their first IVF/ICSI cycle and very few had suffered repeated implantation failure (10%) following ≥3 IVF/ICSI cycles. A subgroup analysis in women with no previous IVF attempts reported no benefits in the ongoing pregnancy rate between the two groups. Nevertheless, the analysis did not have enough power to detect any significant difference. Also, and as noted by Nastri et al. in a recent editorial, all women in the series by Yeung et al. had undergone uterine procedures that may have caused previous injury to the endometrium (hysterectomy or saline sonography) in the 3 months prior to the IVF cycle (Nastri et al., 2015a) . Tk et al. have recently published their results from an RCT with 111 women with at least one previous failed IVF (Tk et al., 2017) . No significant difference in CPR (per embryo transfer) was found between women undergoing ES in the cycle preceding IVF and the control non-ES group (34.09% vs 27.65%; OR 1.35, 95% CI, 0.55-3.30, P = 0.5). Less than 10% of women, however, had undergone ≥3 previous IVF/ICSI cycles. No Missing data 0 0 $ Considering the treatment effectively received. *The rate of miscarriage was defined as the number of lost pregnancies between week 12 and week 20 divided by the number of ongoing pregnancies at week 12. § Measure of risk analyses could not be performed due to the small number of events. NA = not applicable; ITT = intention-to-treat; ES = endometrial scratch; HR = hazard ratio; OR = odds ratio; CI = confidence interval.
analyses were carried out in the subgroup of women with <3 IVF attempts due to the small sample size. Mahran et al. on the other hand, randomized 400 patients undergoing their first IVF/ICSI cycle to undergo either ES in luteal phase of the preceding cycle or no treatment and found that outcomes (implantation, live birth, clinical pregnancy rates) were significantly higher in patients undergoing ES (P < 0.05). As in the study by Yeung et al. all women had undergone a hysteroscopic evaluation, which may have caused prior injury to the endometrium (Mahran et al., 2016) . In addition to differences in the patients included (e.g. number of previous failed attempts), discrepant results among studies may arise from the heterogeneity in terms of the technique used for ES (Pipelle versus aspiration (Yeung et al., 2014) ), the degree of scratch (Pipelle vs hysteroscopy (Shohayeb and El-Khayat, 2012) ), the number of interventions (one procedure vs multiple procedures (Öztürk İnal et al., 2012) ) and the timing of the intervention. In our study, ES was performed in the luteal phase (between Days 20 and 24). In 9 of the 14 RCTs included in the Cochrane review, ES was performed in the luteal phase of the cycle preceding the IVF; in one study ES was performed in the follicular phase; in two studies two ES were done -one in the luteal phase and one in the follicular phase; and in two studies ES procedures were performed in the same cycle of IVF. Comparing outcomes in these studies did not lead to a clear conclusion on the optimal time to do the ES. Liu et al. recently carried out an RCT and found that performing the ES in the proliferative phase versus the luteal phase had no impact on outcomes (Liu et al., 2017) . Karimzade et al. reported that performing ES in the transfer cycle on the day of oocyte retrieval had detrimental effects (Karimzade et al., 2010) .
Mak et al. conducted a RCT to assess the impact of ES in women using frozen embryos and found no difference in clinical pregnancy and implantation rates between the ES group and the non-ES group (Mak et al., 2017) .
In terms of safety, our study demonstrated that ES is a welltolerated procedure; results are in good agreement with previous reports. No cases of endometritis were reported in this study.
One of the limitations of this study is that it failed to reach the planned sample size. After an intermediate analysis of the primary endpoint, an independent monitoring committee recommended terminating recruitment to the trial. However, given the lower CPR in the ES group in our study, the superiority of ES compared to non-ES would not have been shown even if we had reached the planned study size. Another limitation of this RCT is subject to performance bias; ES was performed by different persons meaning the results were operator dependent.
In conclusion, this study is an important contribution to the body of evidence required for the use of ES in routine practice. Our results show that ES does not improve CPR in women with zero or one previous failed IVF cycle under the technical conditions employed in this study. Further research should focus on subgroup analyses in order to better define what population will benefit from the procedure.
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